Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Tissue Barriers|May 4, 2016
HIV and viral protein effects on the blood brain barrierMaryPeace McRae
American Journal of Pharmaceutical Education|March 22, 2019
Identifying Components of Success Within Health Sciences-Focused Mentoring Programs Through a Review of the LiteratureMaryPeace McRae, Kristin M Zimmerman
Neuroscience Letters|February 1, 2021
Treating viruses in the brain: Perspectives from NeuroAIDSMelanie R Nicol, MaryPeace McRae
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 3, 2020
Opioid and neuroHIV Comorbidity - Current and Future PerspectivesSylvia Fitting, MaryPeace McRae, Kurt F Hauser
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|May 20, 2011
Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected AdultsPatrick G Clay, Marypeace McRae, Jean-Pierre Laurent
Current Infectious Disease Reports|September 21, 2017
New Drugs in the Pipeline for the Treatment of HIV: a ReviewLeigh Anne Hylton Gravatt, Crystal R Leibrand, Sulay Patel, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
"One pill, once daily": what clinicians need to know about Atriplatrade markPatrick G Clay, Tracey Ah Taylor, Alan G Glaros, et al.
Obstetrics and Gynecology|July 20, 2011
Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenzaPatrick G Clay, Raghavendra B Adiga, Tracey A H Taylor, et al.
Pageof 4